Foghorn Therapeutics Inc.

NASDAQ: FHTX · Real-Time Price · USD
5.04
-0.06 (-1.18%)
At close: Aug 19, 2025, 10:41 AM

Foghorn Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-86.62M -98.43M -108.88M -101.32M
Depreciation & Amortization
3.12M 3.45M 3.32M 3.23M
Stock-Based Compensation
11.89M 16.19M 14.34M 8.38M
Other Working Capital
-29.79M -42.73M -20.07M 336.48M
Other Non-Cash Items
3.47M 2.56M 3.29M 4.61M
Deferred Income Tax
n/a n/a n/a 1.41M
Change in Working Capital
-32.27M -41.88M 281.55M 33.44M
Operating Cash Flow
-100.41M -118.11M 193.61M -50.25M
Capital Expenditures
-906K -1.22M -1.21M -3.31M
Cash Acquisitions
n/a n/a 243.11M -39.49M
Purchase of Investments
-261.47M -73.9M -409.35M -99.98M
Sales Maturities Of Investments
232.47M 219.57M 166.23M 139.47M
Other Investing Acitivies
n/a n/a -243.11M 39.49M
Investing Cash Flow
-29.9M 144.45M -244.32M 36.17M
Debt Repayment
n/a n/a n/a -21.2M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
2.03M 1.78M 1.76M 1.42M
Financial Cash Flow
105.43M 1.78M 1.76M 22.42M
Net Cash Flow
-24.88M 28.12M -48.95M 8.34M
Free Cash Flow
-101.31M -119.33M 192.4M -53.56M